Meeting of the National Vaccine Advisory Committee, 4147 [2013-00950]

Download as PDF 4147 Federal Register / Vol. 78, No. 13 / Friday, January 18, 2013 / Notices hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Number of respondents Form name Number of responses per respondent Average burden per response (in hours) Total burden hours Adult Viral Hepatitis Prevention Coordinators ............................................... State and local health departments ............................................................... Community-based organizations ................................................................... National organizations ................................................................................... Correctional facilities ...................................................................................... Healthcare providers ...................................................................................... 4 16 12 12 12 12 1 1 1 1 1 1 1.5 .75 .5 .5 .5 .5 6 12 6 6 6 6 Total ........................................................................................................ ........................ ........................ .......................... 42 OASH specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Darius Taylor, Deputy Information Collection Clearance Officer. [FR Doc. 2013–01022 Filed 1–17–13; 8:45 am] BILLING CODE 4150–28–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. AGENCY: ACTION: Notice of meeting. As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting. The meeting is open to the public. Preregistration is required for both public attendance and comment. Individuals who wish to attend the meeting and/or participate in the public comment session should register at http:// www.hhs.gov/nvpo/nvac, email nvpo@hhs.gov, or call 202–690–5566 and provide name, organization, and email address. DATES: The meeting will be held on February 5–6, 2013. The meeting times and agenda will be posted on the NVAC mstockstill on DSK4VPTVN1PROD with SUMMARY: VerDate Mar<15>2010 16:52 Jan 17, 2013 Jkt 229001 Web site at http://www.hhs.gov/nvpo/ nvac as soon as they become available. ADDRESSES: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, Room 800, 200 Independence Avenue SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. Department of Health and Human Services, Room 715–H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: (202) 690–5566; Fax: (202) 690– 4631; email: nvpo@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The National Vaccine Advisory Committee was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. Among the topics to be discussed at the NVAC meeting include the Affordable Care Act, pertussis, polio eradication, global vaccination, and HPV vaccine coverage. The meeting agenda will be posted on the NVAC Web site: http://www.hhs.gov/nvpo/ nvac prior to the meeting. Public attendance at the meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the National Vaccine Program Office at the address/phone listed above at least one week prior to the meeting. Members of PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 the public will have the opportunity to provide comments at the NVAC meeting during the public comment periods on the agenda. Individuals who would like to submit written statements should email or fax their comments to the National Vaccine Program Office at least five business days prior to the meeting. Dated: January 10, 2013. Bruce Gellin, Director, National Vaccine Program Office, Executive Secretary, National Vaccine Advisory Committee. [FR Doc. 2013–00950 Filed 1–17–13; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Toxic Substances and Disease Registry [ATSDR–277] Notice of Development of Set 26 Toxicological Profiles Agency for Toxic Substances and Disease Registry (ATSDR), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice. This notice announces the development of Set 26 Toxicological Profiles, which will consist of three updated profiles and two new profiles. Draft for Public Comment versions of these profiles will be available to the public on or about October 17, 2013. Electronic access to these documents will be available at the ATSDR Web site: http://www.atsdr.cdc.gov/toxprofiles/ index.asp. SUMMARY: Set 26 Toxicological Profiles The following toxicological profiles are now being developed: E:\FR\FM\18JAN1.SGM 18JAN1

Agencies

[Federal Register Volume 78, Number 13 (Friday, January 18, 2013)]
[Notices]
[Page 4147]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-00950]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a 
meeting. The meeting is open to the public. Pre-registration is 
required for both public attendance and comment. Individuals who wish 
to attend the meeting and/or participate in the public comment session 
should register at http://www.hhs.gov/nvpo/nvac, email nvpo@hhs.gov, or 
call 202-690-5566 and provide name, organization, and email address.

DATES: The meeting will be held on February 5-6, 2013. The meeting 
times and agenda will be posted on the NVAC Web site at http://www.hhs.gov/nvpo/nvac as soon as they become available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, Room 800, 200 Independence Avenue SW., Washington, 
DC 20201.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. 
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 
(202) 690-5566; Fax: (202) 690-4631; email: nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The National Vaccine Advisory Committee was 
established to provide advice and make recommendations to the Director 
of the National Vaccine Program on matters related to the Program's 
responsibilities. The Assistant Secretary for Health serves as Director 
of the National Vaccine Program.
    Among the topics to be discussed at the NVAC meeting include the 
Affordable Care Act, pertussis, polio eradication, global vaccination, 
and HPV vaccine coverage. The meeting agenda will be posted on the NVAC 
Web site: http://www.hhs.gov/nvpo/nvac prior to the meeting.
    Public attendance at the meeting is limited to space available. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the National Vaccine Program Office at the address/phone listed 
above at least one week prior to the meeting. Members of the public 
will have the opportunity to provide comments at the NVAC meeting 
during the public comment periods on the agenda. Individuals who would 
like to submit written statements should email or fax their comments to 
the National Vaccine Program Office at least five business days prior 
to the meeting.

    Dated: January 10, 2013.
Bruce Gellin,
Director, National Vaccine Program Office, Executive Secretary, 
National Vaccine Advisory Committee.
[FR Doc. 2013-00950 Filed 1-17-13; 8:45 am]
BILLING CODE P